FDA OK’s Fast Track Status to mRNA RSV Vaccine
The FDA has granted Fast Track designation to Moderna's investigational single-dose mRNA-1345 vaccine against the respiratory syncytial virus (RSV) for people over 60 years of age.
Tag: RSV
All
Latest
All
Latest
Clinical Trial for RSV Vaccine Underway
A Phase 1 study will examine the safety of an experimental intranasal vaccine and its ability to induce an immune response to respiratory syncytial virus (RSV).
All
Latest
Can Ginseng Treat, Prevent Influenza and RSV?
Through trials with mice, researchers believe red ginseng extract improves the survival of human lung epithelial cells infected with the influenza A virus.
